Immutep • IMMP
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Marc Voigt$324.4M
Market Cap • 26/04/20241987
(há 37 anos)
1988
(36 years ago)
NASDAQ
Listagem
Sydney
Sede • NSW35
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
IMMPSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.